Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
This study is currently recruiting participants.
Verified April 2014 by Amgen
Daiichi Sankyo Inc.
Information provided by (Responsible Party):
First received: April 28, 2011
Last updated: April 16, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||October 2018|
|Estimated Primary Completion Date:||May 2016 (Final data collection date for primary outcome measure)|